Christina Isabella Herold MD

Breast Cancer, Hematologic Oncology

Instructor in Medicine, Dana-Farber Cancer Institute, Harvard Medical School

450 Brookline AvenueSuite YC-1250Boston, MA 02215
Phone+1 617-632-3800
Fax+1 617-632-2337

Dr. Herold is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Herold's full profile Already have an account?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
Harvard Medical SchoolClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2009 - 2020
NC State Medical License 2006 - 2009
PA State Medical License 2002 - 2006

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012, 2014-2015, 2017

Clinical Trials

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
COMPLETED
PHASE2
GSK1120212+GSK2141795 for Cervical Cancer
TERMINATED
PHASE2

Publications & Presentations

PubMed

12 citations
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer o...
Ana C Garrido-Castro, Noah Graham, Lestat R Ali, Christina Herold, Jennifer Desrosiers
Journal for Immunotherapy of Cancer. 2025-02-25
6 citations
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer.
Mario Campone, François-Clément Bidard, Patrick Neven, Lei Wang, Bin Ling
Breast Cancer Research. 2023-11-10
187 citations
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Joyce F. Liu, Christina I. Herold, Kathryn P. Gray, Richard T. Penson, Neil S. Horowitz
JAMA Oncology. 2019-10-10